Trials / Completed
CompletedNCT01107236
Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction
A Phase 2, Single-center, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group Study of a Single Dose of IW-6118, in Patients Undergoing Third Molar Extraction
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety of IW-6118 when administered as a single oral dose to patients undergoing third molar extraction. Efficacy will be assessed in an exploratory manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IW-6118 | Single dose |
| DRUG | Matching Placebo | Single dose of matching placebo for IW-6118 and/or matching placebo for naproxen sodium |
| DRUG | Naproxen Sodium | Single dose |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2010-04-20
- Last updated
- 2022-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01107236. Inclusion in this directory is not an endorsement.